About
Richard Klausner joined Illumina in September 2013 as Senior Vice President and Chief Medical Officer. Richard is responsible for Illumina’s strategies for advancing genomics into clinical medicine and public health. He is also part of Illumina’s executive management team, which is responsible for directing all aspects of company strategy, planning and operations. Richard is a Scientific Advisor at Cyterix Pharmaceuticals Inc. He co-founded Pathwork Diagnostics, Inc. (Alternative name is Predicant Biosciences Inc.) in 2002. He serves as the Managing Partner at The Column Group LLC. He served as the Chairman of the Strategic Development and Scientific Advisory Council at Sanofi from March 1, 2011 to January 2013. Richard serves as the Chairman of the National Science Education Standards Projects of the National Academy of Science, overseeing the first comprehensive process to provide a vision of scientific literacy in the American educational system and the criteria required to ach
Position in the VCSift Database
- • 8 investors at Illumina are tracked.
- • 1 investors hold the Senior Vice President & Chief Medical Officer role in VCSift. Richard Klausner is one of them.
- • 7,285 investors are based in San Francisco, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- San Francisco, US
Contact Information
Find more investors like Richard
Search Investors